APP and amyloidosis: Collectively, the CPA data strongly suggest that APP transgene activates microglia/macrophages, and myeloid Arg1 deficiency during amyloidosis promotes oligodendrocytes, by which CNS cell types presumably drive the regulation of neurodegeneration.